U.S. markets open in 5 hours 17 minutes
  • S&P Futures

    3,333.75
    -12.25 (-0.37%)
     
  • Dow Futures

    27,365.00
    -117.00 (-0.43%)
     
  • Nasdaq Futures

    11,343.50
    -51.25 (-0.45%)
     
  • Russell 2000 Futures

    1,498.20
    -8.30 (-0.55%)
     
  • Crude Oil

    40.27
    -0.33 (-0.81%)
     
  • Gold

    1,886.40
    +4.10 (+0.22%)
     
  • Silver

    23.70
    +0.10 (+0.43%)
     
  • EUR/USD

    1.1673
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    0.6630
    0.0000 (0.00%)
     
  • Vix

    26.71
    +0.33 (+1.25%)
     
  • GBP/USD

    1.2876
    +0.0034 (+0.27%)
     
  • USD/JPY

    105.6140
    +0.0950 (+0.09%)
     
  • BTC-USD

    10,731.16
    +28.66 (+0.27%)
     
  • CMC Crypto 200

    230.23
    +6.31 (+2.82%)
     
  • FTSE 100

    5,885.95
    -41.98 (-0.71%)
     
  • Nikkei 225

    23,539.10
    +27.48 (+0.12%)
     

Autoimmune Disease Diagnosis Market To Reach USD 7.37 Billion By 2027 | Reports and Data

Reports and Data

Increasing incidences of autoimmune diseases across the globe and the growing research interest in autoimmune disease diagnosis are boosting market demand.

New York, Aug. 20, 2020 (GLOBE NEWSWIRE) -- The Global Autoimmune Disease Diagnosis Market is forecast to reach USD 7.37 Billion by 2027, according to a new report by Reports and Data. An increase in the awareness of autoimmune diseases through education, research, and advocacy is driving market demand.

An autoimmune disease is a condition wherein one’s immune system mistakenly attacks the body itself. Normally, the immune system guards the body against foreign invaders, but in an autoimmune disease, the immune system mistakes a part of the body as foreign and starts attacking healthy cells.

Multiple Sclerosis is a disabling condition of the central nervous system that impairs the flow of information within the brain and between the body and the brain. Increasing research related to the signs and treatments for the disease is expected to drive the market growth. Another challenge faced by the Multiple Sclerosis therapeutics market is the lack of awareness among the people associated with the Multiple Sclerosis condition. The demand for Multiple Sclerosis is expected to increase owing to the new drug developments for treating Multiple Sclerosis, which in turn will drive the demand for the autoimmune disease diagnosis market.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3436

COVID-19 Impact Analysis:

One of the major impacts of COVID-19 on the market has been elevated demand for point-of-care immunodiagnostic tests. The development of these easy-to-use and rapid devices to support testing outside of laboratory settings has been a response of diagnostic test manufacturers to shortages of laboratory-based molecular testing capacity. The increasing focus on large screen testing for COVID-19 has led to a shortage in the supply for diagnostic kits for autoimmune diseases. Diagnostic companies are under immense pressure to provide reliable point-of-care testing capacities

Further key findings from the report suggest

  • Consumables and Assay Kits dominated the market for autoimmune disease diagnostic and is forecasted to grow with a CAGR of 8.2% during the forecast period. The segment is driven by an increasing need for rapid diagnosis of autoimmune disease.

  • Rheumatoid arthritis (RA) is an inflammatory disease that affects the joints. The condition worsens over time unless the inflammation is slowed or stopped. The disease rarely goes into remission without treatment. Statistics show that out of every 100,000 people, 41 are diagnosed with RA every year. Women are about 2-3 times more likely to get RA than men. Hormones in both genders may play a role in either preventing or triggering it.

  • Hospital pharmacies are expected to hold a larger market share owing to an increase in the autoimmune disease consultations in clinics and hospitals. The prolonged use of these medications can lead to drug resistance, which compels the patients to refer to a rheumatologist and follow guided therapies. Moreover, the number of OTC Drugs available for treatment is insufficient, which, in turn, is further propelling the growth of this segment.

  • The Asia Pacific market is anticipated to witness high growth during the forecast period owing to the increasing healthcare expenditure. Furthermore, the low cost of manufacturing in India and China has resulted in an increase in the production facilities, which attracts pharmaceutical and biotechnological giants to the region.

  • Key participants include Siemens, Danaher, Thermo Fisher Scientific, Grifols, Abbott, Bio-Rad Laboratories, Werfen, Trinity Biotech, Hycor Biomedical, and Euroimmun, among others.

BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3436

For the purpose of this report, Reports and Data has segmented the Global Autoimmune Disease Diagnosis Market on the basis of product, test type, disease, end-user, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Instruments

  • Consumables and Assay Kits

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Inflammatory markers

  • Routine laboratory tests

  • Autoantibodies and immunologic tests

  • Others tests

Disease Outlook (Revenue, USD Billion; 2017-2027)

  • Systemic Lupus Erythematosus

  • Thyroiditis

  • Rheumatoid Arthritis

  • Sjögren’s Syndrome

  • Scleroderma

  • Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals

  • Clinical Laboratories

  • Other

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/autoimmune-disease-diagnosis-market

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • U.K.

  • France

  • Benelux

  • Rest of Europe

  • Asia Pacific

  • China

  • Japan

  • South Korea

  • Rest of APAC

  • Latin America

  • Brazil

  • Rest of LATAM

  • Middle East & Africa

  • Saudi Arabia

  • UAE

  • Rest of MEA

Take a Look at our Related Reports:

Ovulation Testing Kits Market By Products (Ovulation Urine Test, Digital Ovulation Tests), By Sales Channel (Pharmacies, Supermarkets), And By End Use (Homecare Settings, Fertility Clinics) Forecasts To 2027

Cardiovascular Monitoring and Diagnostic Devices Market By Type (Resting ECG System, Stress ECG System, Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management System), And Region- Global Forecast To 2027

Wearable Robots Market By Type (Powered Exoskeletons, Passive Exoskeletons), By Application (Healthcare, Military And Defence, Industries, Others), And Region- Global Forecast To 2027

Sphygmomanometers Market By Type (Mercury, Aneroid, Digital), By Application Type (Hospital, Clinic, Family, Others), And Region-Global Forecast To 2027

DNA Microarray Market By Type (Complementary DNA Microarrays (cDNA), Oligonucleotide DNA Microarrays (oDNA)), By Application (Gene Expression, Genotyping, Genome Cytogenetics, Others), And Region- Global Forecast To 2027

Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For HCG, Home Blood Test Kits for HCG, Others), By Product (Digital Devices, Strips/Dip Sticks & Cards, Others), And By Sales Channel (Pharmacies, Drug Stores, Others), Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

CONTACT: Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com